References
- Andresciani F, Faiella E, Altomare C, Pacella G, Beomonte Zobel B, Grasso RF. Reversible electrochemotherapy (ECT) as a treatment option for local RCC recurrence in solitary kidney. Cardiovasc Intervent Radiol 2020; 43: 1091-4. doi: 10.1007/s00270-020-02498-2
- Ritter A, Bruners P, Isfort P, Barabasch A, Pfeffer J, Schmitz J, et al. Electroporation of the liver: more than 2 concurrently active, curved electrodes allow new concepts for irreversible electroporation and electro-chemotherapy. Technol Cancer Res Treat 2018; 17: 153303381880999. doi: 10.1177/1533033818809994
- Probst U, Fuhrmann I, Beyer L, Wiggermann P. Electrochemotherapy as a new modality in interventional oncology: a review. Technol Cancer Res Treat 2018; 17: 153303381878532. doi: 10.1177/1533033818785329
- Leiter U, Gutzmer R, Alter M, Ulrich C, Meiwes A, Heppt MV, et al. [Cutaneous squamous cell carcinoma]. [German]. Hautarzt 2020; 71: 597-606. doi: 10.1007/s00105-020-04620-4
- Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13. doi: 10.1016/j.ejcsup.2006.08.002
- Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncologica 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602
- Mali B, Miklavcic D, Campana LG, Cemazar M, Sersa G, Snoj M, et al. Tumor size and effectiveness of electrochemotherapy. Radiol Oncol 2013; 47: 32-41. doi: 10.2478/raon-2013-0002
- Mir LM, Orlowski S, Belehradek J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer Clin Oncol 1991; 27: 68-72. doi: 10.1016/0277-5379(91)90064-K
- Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993; 72: 3694-700. doi: 10.1002/1097-0142(19931215) 72:12<3694::aid-cncr2820721222>3.0.co;2-2
- Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 1998; 9: 319-25. doi: 10.1097/00001813-199804000-00005
- Mir LM, Glass LF, Sersa G, Teissié J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77: 2336-42. doi: 10.1038/bjc.1998.388
- Ferioli M, Perrone AM, Buwenge M, Arcelli A, Zamagni A, Macchia G, et al. Electrochemotherapy of skin metastases from breast cancer: a systematic review. Clin Exp Metastasis 2021; 38: 1-10. doi: 10.1007/s10585-020-10063-x
- Crimini E, Roberto M, Degli Effetti V, Marchetti P, Botticelli A, Schipilliti FM, et al. Electrochemotherapy as promising treatment option in rare recurrent cutaneous neoplasm of the scalp: case report of an elderly patient. Case Rep Oncol Med 2019; 2019: 2507642. doi: 10.1155/2019/2507642
- Benevento R, Santoriello A, Perna G, Canonico S. Electrochemotherapy of cutaneous metastasis from breast cancer in elderly patients: a preliminary report. BMC Surg 2012; 12(Suppl 1): S6. doi: 10.1186/1471-2482-12-S1-S6
- Campana LG, Galuppo S, Valpione S, Brunello A, Ghiotto C, Ongaro A, et al. Bleomycin electrochemotherapy in elderly metastatic breast cancer patients: clinical outcome and management considerations. J Cancer Res Clin Oncol 2014; 140: 1557-65. doi: 10.1007/s00432-014-1691-6
- Seyed Jafari SM, Jabbary Lak F, Gazdhar A, Shafighi M, Borradori L, Hunger RE. Application of electrochemotherapy in the management of primary and metastatic cutaneous malignant tumours: a systematic review and meta-analysis. Eur J Dermatol 2018; 28: 287-313. doi: 10.1684/ejd.2018.3291
- Borgognoni L, Pescitelli L, Gerlini G, Brandani P, Gelli R, Giannotti V, et al. Efficacy of electrochemotherapy in the treatment of cutaneous melanoma metastases and rare non-melanoma skin cancer. Anticancer Res 2020; 40: 6485-92. doi: 10.21873/anticanres.14670
- Caracò C, Mozzillo N, Marone U, Simeone E, Benedetto L, Di Monta G, et al. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis. BMC Cancer 2013; 13: 564. doi: 10.1186/1471-2407-13-564
- Bertino G, Sersa G, De Terlizzi F, Occhini A, Plaschke CC, Groselj A, et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results of the treatment of skin cancer. Eur J Cancer 2016; 63: 41-52. doi: 10.1016/j.ejca.2016.05.001
- Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019). Eur J Cancer 2020; 138: 30-40. doi: 10.1016/j.ejca.2020.06.020
- Todorovic V, Sersa G, Flisar K, Cemazar M. Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells. Radiol Oncol 2009; 43: 264-73. doi: 10.2478/v10019-009-0037-5
- Bianchi G, Campanacci L, Ronchetti M, Donati D. Electrochemotherapy in the treatment of bone metastases: a phase II trial. World J Surg 2016; 40: 3088-94. doi: 10.1007/s00268-016-3627-6.
- Edhemovic I, Brecelj E, Gasljevic G, Marolt Music M, Gorjup V, Mali B, et al. Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol 2014; 110: 320-7. doi: 10.1002/jso.23625
- Coletti L, Battaglia V, De Simone P, Turturici L, Bartolozzi C, Filipponi F. Safety and feasibility of electrochemotherapy in patients with unresectable colorectal liver metastases: a pilot study. Internat J Surg 2017; 44: 26-32. doi: 10.1016/j.ijsu.2017.06.033
- Edhemovic I, Brecelj E, Cemazar M, Boc N, Trotovsek B, Djokic M, et al. Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. Eur J Surg Oncol 2020; 46: 1628-33. doi: 10.1016/j.ejso.2020.04.037
- Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, et al. Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 2011; 10: 475-85. doi: 10.7785/tcrt.2012.500224
- Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol 2018; 44: 651-7. doi: 10.1016/j.ejso.2018.01.090
- Djokic M, Dezman R, Cemazar M, Stabuc M, Petric M, Smid LM, et al. Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancement. Radiol Oncol 2020; 54: 347-52. doi: 10.2478/raon-2020-0038
- Tarantino L, Busto G, Nasto A, Nasto RA, Tarantino P, Fristachi R, et al. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a feasibility study. Eur J Surg Oncol 2018; 44: 1603-9. doi: 10.1016/j.ejso.2018.06.025
- Granata V, Palaia R, Albino V, Piccirillo M, Venanzio Setola S, Petrillo A, et al. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a case report. Eur Review Med Pharmacol Sci 2020; 24: 7051-7. doi: 10.26355/eurrev_202006_21698
- Bhutiani N, Li Y, Zheng Q, Pandit H, Shi X, Chen Y, et al. Electrochemotherapy with irreversible electroporation and FOLFIRINOX improves survival in murine models of pancreatic adenocarcinoma. Ann Surg Oncol 2020; 27: 4348-59. doi: 10.1245/s10434-020-08782-2
- Bhutiani N, Agle S, Li Y, Li S, Martin RCG. Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma. J Surg Oncol 2016; 114: 181-6. doi: 10.1002/jso.24288
- Martin RCG, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, et al. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg 2015; 262: 486-94; discussion 492-494. doi: 10.1097/SLA.0000000000001441
- Huang K-W, Yang P-C, Pua U, Kim M-D, Li S-P, Qiu Y-D, et al. The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma. J Surg Oncol 2018; 118: 31-6. doi: 10.1002/jso.25110
- Holland MM, Bhutiani N, Kruse EJ, Weiss MJ, Christein JD, White RR, et al. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry. HPB (Oxford) 2019; 21: 1024-31. doi: 10.1016/j.hpb.2018.12.004
- Perrone AM, Cima S, Pozzati F, Frakulli R, Cammelli S, Tesei M, et al. Palliative electro-chemotherapy in elderly patients with vulvar cancer: a phase II trial: electro-chemotherapy in vulvar cancer. J Surg Oncol 2015; 112: 529-32. doi: 10.1002/jso.24036
- Corrado G, Cutillo G, Fragomeni SM, Bruno V, Tagliaferri L, Mancini E, et al. Palliative electrochemotherapy in primary or recurrent vulvar cancer. Int J Gynecol Cancer 2020; 30: 927-31. doi: 10.1136/ijgc-2019-001178
- Merlo S, Vivod G, Bebar S, Bošnjak M, Čemažar M, Serša G, et al. Literature review and our experience with bleomycin-based electrochemotherapy for cutaneous vulvar metastases from endometrial cancer. Technol Cancer Res Treat 2021; 20: 15330338211010134. doi: 10.1177/15330338211010134
- Egeland C, Baeksgaard L, Johannesen HH, Löfgren J, Plaschke CC, Svendsen LB, et al. Endoscopic electrochemotherapy for esophageal cancer: a phase I clinical study. Endosc Int Open 2018; 6: E727-34. doi: 10.1055/a-0590-4053
- Falk Hansen H, Bourke M, Stigaard T, Clover J, Buckley M, O’Riordain M, et al. Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study. Endosc Int Open 2020; 8: E124-32. doi: 10.1055/a-1027-6735